Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Knapp

Showing results (261-270 of 266) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 266 results.
Biological Psychiatry|April 28, 2004
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patientsGeorg Berding, Kirsten Müller-Vahl, Udo Schneider, et al.
Neuroendocrinology|February 22, 2007
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic)Ola Nilsson, Erik Van Cutsem, Gianfranco Delle Fave, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registryDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Zentralblatt Fur Chirurgie|June 20, 2008
[Diagnosis and treatment of colorectal liver metastases - workflow]R T Grundmann, P Hermanek, S Merkel, et al.
Pageof 27

Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Biological Psychiatry|April 28, 2004
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patientsGeorg Berding, Kirsten Müller-Vahl, Udo Schneider, et al.
Neuroendocrinology|February 22, 2007
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic)Ola Nilsson, Erik Van Cutsem, Gianfranco Delle Fave, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registryDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Zentralblatt Fur Chirurgie|June 20, 2008
[Diagnosis and treatment of colorectal liver metastases - workflow]R T Grundmann, P Hermanek, S Merkel, et al.
Pageof 27